Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
Jiangxi Cardiovascular Research Institute, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, Jiangxi Provincial, China.
BMC Endocr Disord. 2024 Nov 7;24(1):238. doi: 10.1186/s12902-024-01769-0.
The Metabolic Insulin Resistance Score (METS-IR) is a non-invasive proxy for insulin resistance (IR) that has been newly developed in recent years and has been shown to be associated with diabetes risk. Our aim was to assess the predictive value of METS-IR for the future development of diabetes and its temporal differences in people of different sex, age, and body mass index (BMI).
The current study included 15,453 baseline non-diabetic subjects in the NAGALA cohort and then grouped according to the World Health Organization's (WHO) recommended criteria for age and BMI. Multivariate Cox regression and time-dependent receiver operator characteristics (ROC) curves were used to analyze the value of METS-IR in assessing and predicting the risk of diabetes in people of different sexes, ages, and BMIs.
373 individuals developed diabetes during the observation period. By multivariate COX regression analysis, the development of future diabetes was significantly associated with increased METS-IR, and this positive association was stronger in women than in men and in individuals < 45 years than in individuals ≥ 45 years; while no significant differences were observed between non-obese and overweight/obesity individuals. Using time-dependent ROC analysis we also assessed the predictive value of METS-IR for future diabetes at a total of 11-time points between 2 and 12 years. The results showed that METS-IR had a higher predictive value for the future development of diabetes in women or individuals < 45 years of age compared to men or individuals ≥ 45 years of age for almost the entire follow-up period. Furthermore, across different BMI categories, we also found that in the short term (3-5 years), METS-IR had a higher predictive value for the development of diabetes in individuals with overweight/obesity, while in the medium to long term (6-12 years), METS-IR was more accurate in predicting the development of diabetes in non-obese individuals.
Our study showed that METS-IR was independently associated with the development of future diabetes in a non-diabetic population. METS-IR was a good predictor of diabetes, especially for women and individuals < 45 years old for predicting the future risk of developing diabetes at all times.
代谢胰岛素抵抗评分(METS-IR)是一种新开发的胰岛素抵抗(IR)的非侵入性替代指标,已被证明与糖尿病风险相关。我们的目的是评估 METS-IR 对不同性别、年龄和体重指数(BMI)人群未来发生糖尿病的预测价值及其时间差异。
本研究纳入了 NAGALA 队列中 15453 名基线非糖尿病患者,然后根据世界卫生组织(WHO)推荐的年龄和 BMI 标准进行分组。多变量 Cox 回归和时间依赖性接受者操作特征(ROC)曲线用于分析 METS-IR 在评估和预测不同性别、年龄和 BMI 人群糖尿病风险中的价值。
在观察期间,373 人发生糖尿病。通过多变量 COX 回归分析,未来糖尿病的发生与 METS-IR 的增加显著相关,且这种正相关在女性中比在男性中更强,在<45 岁的个体中比在≥45 岁的个体中更强;而在非肥胖和超重/肥胖个体之间未观察到显著差异。使用时间依赖性 ROC 分析,我们还评估了 METS-IR 在 2 至 12 年内总共 11 个时间点对未来糖尿病的预测价值。结果表明,在整个随访期间,METS-IR 对女性或<45 岁个体未来糖尿病的发生具有更高的预测价值,而对男性或≥45 岁个体则较低。此外,在不同 BMI 类别中,我们还发现,在短期(3-5 年)内,METS-IR 对超重/肥胖个体发生糖尿病的预测价值较高,而在中至长期(6-12 年)内,METS-IR 对非肥胖个体发生糖尿病的预测更为准确。
我们的研究表明,METS-IR 与非糖尿病人群未来发生糖尿病独立相关。METS-IR 是糖尿病的良好预测指标,尤其是对于女性和<45 岁的个体,在所有时间点都能很好地预测未来发生糖尿病的风险。